Trials / Completed
CompletedNCT01929096
Compound Edaravone Injection for Acute Ischemic Stroke
Compound Edaravone Injection for Acute Ischemic Stroke, a Multi-center, Randomized, Double-blind, Multi-dose, Parallel, and Controlled Phase II Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 400 (actual)
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
1. To investigate the efficacy and safety of multi-doses Compound Edaravone Injection versus Edaravone Injection for acute ischemic stroke patients; 2. To provide evidence for the design of Compound Edaravone Injection Phase III trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Compound Edaravone Injection | |
| DRUG | Edaravone Injection |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-12-01
- Completion
- 2015-02-01
- First posted
- 2013-08-27
- Last updated
- 2015-07-03
Locations
28 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01929096. Inclusion in this directory is not an endorsement.